Biodistribution of bone marrow mononuclear cells after intra-arterial or intravenous transplantation in subacute stroke patients.
CONCLUSION: BMMNC labeling with technetium-99m allowed imaging for up to 24 h after intra-arterial or intravenous injection in stroke patients.
PMID: 23477395 [PubMed - in process]
Source: Regenerative Medicine - Category: Genetics & Stem Cells Authors: Rosado-de-Castro PH, Schmidt Fda R, Battistella V, Lopes de Souza SA, Gutfilen B, Goldenberg RC, Kasai-Brunswick TH, Vairo L, Silva RM, Wajnberg E, Alvarenga Americano do Brasil PE, Gasparetto EL, Maiolino A, Alves-Leon SV, Andre C, Mendez-Otero R, Rodrig Tags: Regen Med Source Type: research
More News: Brain | Clinical Trials | Genetics | Ischemic Stroke | Liver | Liver Transplant | Lung Transplant | Men | Neurology | Stroke | Transplants | Urology & Nephrology